more so than the average person (I assume)
Drawing a 2.5mg dose At 5mg/ml (2ml water added): Draw 50 units
CROI: Impact of Semaglutide on Weight Change Among People with HIV: A Stratified Analysis by Baseline BMI - (03/11/24) CROI: Effects of Semaglutide on Muscle Structure and Function in the SLIM Liver Study - (03/12/24) CROI: Semaglutide Lowers Some Inflammation Markers in HIV Lipohypertrophy - (03/12/24) CROI: Effects of Semaglutide on Inflammation and Immune Activation in HIV-Associated Lipohypertrophy....people with severe lipoatrophy were excluded from study, so were diabetics & CVD - (03/11/24) CROI: Effects of Semaglutide on Muscle Structure and Function in the SLIM Liver Study - (03/12/24) CROI: Semaglutide Lowers Some Inflammation Markers in HIV Lipohypertrophy - (03/12/24) CROI: Low-Dose Semaglutide Cuts Weight, Triglycerides, and Glucose in HIV MASLD Group - (03/12/24) CROI: Race/Ethnicity and Risk of NAFLD and Clinically Significant Fibrosis in Persons Living with HIV - (03/12/24) CROI: NAFLD and Advanced Fibrosis Are Common in Adults With HIV and Associated With Unique Histology - (03/12/24) CROI: Weight Loss 5.7% at 1 Year With Semaglutide in HIV - Mark Mascolini (03/11/24) 100 NATAP CROI Reports Conference on Retroviruses and Opportunistic Infections Virtual Mar 3 -, Mar 6, 2024
Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers
Tan WJT, Vlajkovic SM (2023) Molecular characteristics of cisplatin-induced ototoxicity and therapeutic interventions
Guidelines from bodies such as the Endocrine Society and AACE (American Association of Clinical Endocrinology) recommend considering GLP-1 RAs (or other anti-obesity medications) in patients with BMI 30, or 27 with weight-related comorbidities, when lifestyle measures alone are insufficient
)
